Abstract: A case-control study was performed to determine the impact of aprotinin or tranexamic acid use on reducing intraoperative blood loss and transfusion needs in complex spine surgery. Sixty-nine patients undergoing complex spine surgery received aprotinin or tranexamic acid. The aprotinin group contained 30 patients (8 men and 22 women) and the tranexamic acid group 39 patients (11 men and 28 women). The following variables were recorded: duration of surgery, number of levels fused, intraoperative and total blood loss, and number of blood units transfused (autologous and allogenic). In addition, various parameters related to blood loss in this type of surgery were calculated. The groups differed with regard to duration of surgery (ap...
BackgroundMultilevel spinal fusions have typically been associated with significant blood loss. Prev...
Abstract Background Degenerative spinal stenosis and instability requiring multilevel spine surgery ...
Tranexamic acid (TXA) is well-established as a versatile oral, intramuscular, and intravenous (IV) a...
Abstract: A case-control study was performed to determine the impact of aprotinin or tranexamic acid...
Routine use of antifibrinolytic agents in spine surgery is still an issue of debate.To gather scient...
Routine use of antifibrinolytic agents in spine surgery is still an issue of debate.To gather scient...
Objective. Tranexamic acid (TXA), an antifibrinolytic agent, interferes with fibrinolysis and has be...
International audienceStudies have shown that antifibrinolytic (aprotinin, tranexamic acid, epsilon-...
Abstract Background Multilevel spinal fusion surgery has typically been associated with significant ...
Objective: Aprotinin reduces the blood loss and transfusion of blood products in children undergoing...
Study Design A randomized double-blind placebo controlled study. Purpose In the present study, we ai...
AbstractObjectiveScoliosis surgery involves major blood loss and frequently requires blood transfusi...
Background. Perioperative tranexamic acid (TXA) use can reduce bleeding and transfusion requirements...
One of the problems that influenced surgeon and anesthesiologist in strumental spinal fusion surgery...
Objective: To compare peri-operative surgical blood loss in laminectomy with spinal fusion surgery, ...
BackgroundMultilevel spinal fusions have typically been associated with significant blood loss. Prev...
Abstract Background Degenerative spinal stenosis and instability requiring multilevel spine surgery ...
Tranexamic acid (TXA) is well-established as a versatile oral, intramuscular, and intravenous (IV) a...
Abstract: A case-control study was performed to determine the impact of aprotinin or tranexamic acid...
Routine use of antifibrinolytic agents in spine surgery is still an issue of debate.To gather scient...
Routine use of antifibrinolytic agents in spine surgery is still an issue of debate.To gather scient...
Objective. Tranexamic acid (TXA), an antifibrinolytic agent, interferes with fibrinolysis and has be...
International audienceStudies have shown that antifibrinolytic (aprotinin, tranexamic acid, epsilon-...
Abstract Background Multilevel spinal fusion surgery has typically been associated with significant ...
Objective: Aprotinin reduces the blood loss and transfusion of blood products in children undergoing...
Study Design A randomized double-blind placebo controlled study. Purpose In the present study, we ai...
AbstractObjectiveScoliosis surgery involves major blood loss and frequently requires blood transfusi...
Background. Perioperative tranexamic acid (TXA) use can reduce bleeding and transfusion requirements...
One of the problems that influenced surgeon and anesthesiologist in strumental spinal fusion surgery...
Objective: To compare peri-operative surgical blood loss in laminectomy with spinal fusion surgery, ...
BackgroundMultilevel spinal fusions have typically been associated with significant blood loss. Prev...
Abstract Background Degenerative spinal stenosis and instability requiring multilevel spine surgery ...
Tranexamic acid (TXA) is well-established as a versatile oral, intramuscular, and intravenous (IV) a...